Financial News
Articles published by Rocket Pharmaceuticals, Inc.
Via Business Wire
Tickers
RCKT
Via Business Wire
Tickers
RCKT
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Participation in 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Appoints Martin L. Wilson as General Counsel and Chief Compliance Officer
December 08, 2021
Via Business Wire
Tickers
RCKT
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Participation in Evercore ISI 4th Annual HEALTHCONx Virtual Conference
November 22, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
November 15, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Participation in Stifel 2021 Virtual Healthcare Conference
November 10, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Progress
November 03, 2021
Via Business Wire
Tickers
RCKT
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
September 30, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources Officer
September 07, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces $26.4 Million Private Placement
August 30, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501
August 16, 2021
Via Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
August 09, 2021
Via Business Wire
Tickers
RCKT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.